American International Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-183
Closed -$27.9K 74
2024
Q1
$27.9K Sell
183
-3
-2% -$499 ﹤0.01% 2887
2023
Q4
$58.3K Sell
186
-5
-3% -$1.81K ﹤0.01% 2781
2023
Q3
$84.7K Sell
191
-3
-2% -$1.35K ﹤0.01% 2600
2023
Q2
$84K Buy
194
+84
+76% +$47.2K ﹤0.01% 2688
2023
Q1
$65.4K Sell
110
-3
-3% -$1.68K ﹤0.01% 2635
2022
Q4
$45.7K Sell
113
-3
-3% -$1.41K ﹤0.01% 2774
2022
Q3
$68K Buy
116
+2
+2% +$1.2K ﹤0.01% 2719
2022
Q2
$62K Sell
114
-9
-7% -$4.55K ﹤0.01% 2801
2022
Q1
$78K Hold
123
﹤0.01% 2681
2021
Q4
$83K Buy
123
+71
+137% +$43.2K ﹤0.01% 2799
2021
Q3
$34K Buy
52
+11
+27% +$9.4K ﹤0.01% 3045
2021
Q2
$42 Buy
+41
New +$35.9K ﹤0.01% 3019

Other funds holding AGL

American International Group's AGL Position: Q2 2024 in Review

American International Group sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 183 shares — an estimated $27.9K sold.

American International Group first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $84.7K in Q3 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • American International Group reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 183 Agilon Health shares in Q2 2024, an estimated $27.9K.
  • American International Group first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • American International Group's Agilon Health position peaked at $84.7K in Q3 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.